146 related articles for article (PubMed ID: 24753747)
1. Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins.
Feng B; Hu P; Lu SJ; Wang R; Du YF
Int J Clin Exp Med; 2014; 7(3):549-57. PubMed ID: 24753747
[TBL] [Abstract][Full Text] [Related]
2. The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses.
Wang P; Jiang S; Cui Y; Yue Z; Su C; Sun J; Sheng S; Tian J
Neuroscience; 2011 Jan; 173():169-78. PubMed ID: 21055450
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophic effects of amyloid precursor protein peptide 165 in vitro.
Yao J; Ma L; Wang R; Sheng S; Ji Z; Zhang J
Brain Res Bull; 2016 Jan; 120():58-62. PubMed ID: 26551064
[TBL] [Abstract][Full Text] [Related]
4. Effects of analog P165 of amyloid precursor protein 5-mer peptide on learning, memory and brain insulin receptors in the rat model of cognitive decline.
Xu BL; Wang R; Meng XH; Zhao ZW; Wang HJ; Ma LN; Dong W; Sheng SL; Ji ZJ
Neurol Sci; 2014 Nov; 35(11):1821-6. PubMed ID: 24946940
[TBL] [Abstract][Full Text] [Related]
5. The β-amyloid precursor protein analog P165 improves impaired insulin signal transduction in type 2 diabetic rats.
Ma L; Shao Z; Wang R; Zhao Z; Zhang X; Ji Z; Sheng S; Xu B; Dong W; Zhang J
Neurol Sci; 2015 Apr; 36(4):593-8. PubMed ID: 25380623
[TBL] [Abstract][Full Text] [Related]
6. N-terminal 5-mer peptide analog P165 of amyloid precursor protein inhibits UVA-induced MMP-1 expression by suppressing the MAPK pathway in human dermal fibroblasts.
Wang Y; Chen H; Wang W; Wang R; Liu ZL; Zhu W; Lian S
Eur J Pharmacol; 2014 Jul; 734():1-8. PubMed ID: 24685639
[TBL] [Abstract][Full Text] [Related]
7. Amyloid precursor protein 17-mer peptide ameliorates hippocampal neurodegeneration in ovariectomized rats.
Meng Y; Wang R; Yang F; Ji ZJ; Fang L; Sheng SL
Neurosci Lett; 2010 Jan; 468(3):173-7. PubMed ID: 19632300
[TBL] [Abstract][Full Text] [Related]
8. Photoprotective effect of the N-terminal 5-mer peptide analog P165 of amyloid precursor protein in human dermal fibroblasts.
Wang Y; Chen H; Lin Y; Wang W; Wang R; Lian S; Zhu W
Chin Med J (Engl); 2014; 127(4):718-23. PubMed ID: 24534229
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation.
Lee AY; Lee MH; Lee S; Cho EJ
J Agric Food Chem; 2017 Dec; 65(49):10719-10729. PubMed ID: 29092397
[TBL] [Abstract][Full Text] [Related]
10. Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice.
Zhu L; Yang L; Zhao X; Liu D; Guo X; Liu P; Chi T; Ji X; Zou L
Psychopharmacology (Berl); 2018 Jan; 235(1):337-349. PubMed ID: 29124300
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
[TBL] [Abstract][Full Text] [Related]
12. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
13. Panaxadiol inhibits synaptic dysfunction in Alzheimer's disease and targets the Fyn protein in APP/PS1 mice and APP-SH-SY5Y cells.
Liang X; Yao Y; Lin Y; Kong L; Xiao H; Shi Y; Yang J
Life Sci; 2019 Mar; 221():35-46. PubMed ID: 30735733
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Memantine on Streptozotocin-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Neurotrophic Factor Decline in Astrocytes.
Rajasekar N; Nath C; Hanif K; Shukla R
Mol Neurobiol; 2016 Dec; 53(10):6730-6744. PubMed ID: 26660109
[TBL] [Abstract][Full Text] [Related]
15. The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β-amyloid peptide.
Lanchec E; Désilets A; Béliveau F; Flamier A; Mahmoud S; Bernier G; Gris D; Leduc R; Lavoie C
J Biol Chem; 2017 Dec; 292(50):20669-20682. PubMed ID: 29054928
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
19. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside Hp-s1 Analogue Inhibits Amyloidogenic Toxicity in Alzheimer's Disease Model Cells.
Tsai YF; Yang DJ; Ngo TH; Shih CH; Wu YF; Lee CK; Phraekanjanavichid V; Yen SF; Kao SH; Lee HM; Huang VS; Shieh JC; Lin YF
ACS Chem Neurosci; 2019 Jan; 10(1):528-536. PubMed ID: 30346715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
